Early Phase 1 Chronic Fatigue Syndrome Trial, By Invitation NCT07209527 Sponsor: Truway Health, Inc. Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Early Phase 1 Chronic Fatigue Syndrome Trial, By Invitation

NCT07209527
By Invitation Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old (inclusive)
  • You are able to understand what the study involves and are willing to sign a consent form
  • You have been diagnosed with the condition this trial is studying, based on recognised medical or diagnostic standards
  • Your current treatment (whether medication or another type of care) has stayed the same for at least 4 weeks before your initial screening appointment
  • You are willing and able to attend all required visits, complete all procedures, and take part in any follow-up check-ins

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have a known allergy or sensitivity to any ingredients in the treatment being tested in this trial
  • You have another health condition (such as a heart, liver, kidney, or mental health condition) that is not well-controlled or is currently unstable
  • You have taken part in another clinical trial involving a treatment or intervention within the last 3 months
  • You have a cognitive difficulty or a language barrier that would make it hard to give informed consent or accurately report how you are feeling during the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
By Invitation
Phase
Early Phase 1
Sponsor
Truway Health, Inc.
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
1 October 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of Early Detection of Chronic Conditions; Improvement in Glycemic Control

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov